Related Experiment Video
Updated: Oct 22, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Autophagy Modulators in Cancer: Focus on Cancer Treatment
1Drug Discovery Platform Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Abstract:
Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains difficult to equally apply autophagy modulators to cancer therapy because autophagy is a double-edged sword in cancer: it can be tumor-suppressive or tumor-protective. Therefore, the precise mechanisms of autophagy modulators and their varied responsiveness to each cancer type should be addressed in detail. This study will describe the precise mechanisms of developing various autophagy modulators, their current therapeutic applications and future perspectives.
Insights
Autophagy, a cellular process, plays a complex role in cancer therapy. Understanding its dual function is crucial for developing effective autophagy modulators to combat treatment-resistant cancers.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Uncontrolled autophagy is linked to cancer development and resistance to therapy.
- Autophagy's dual role (tumor-suppressive or tumor-protective) complicates its therapeutic application.
- Current cancer treatments face challenges due to autophagy's complex involvement.
Purpose of the Study:
- To elucidate the precise mechanisms of autophagy modulators.
- To detail the varied responsiveness of different cancer types to autophagy modulation.
- To provide an overview of current therapeutic applications and future perspectives for autophagy modulators in cancer.
Main Methods:
- Review of existing literature on autophagy mechanisms.
- Analysis of preclinical and clinical trial data on autophagy modulators.
- Comparative analysis of autophagy modulator efficacy across diverse cancer types.
Main Results:
- Autophagy's role in cancer is context-dependent, acting as both a suppressor and protector.
- Specific autophagy modulators exhibit differential effects based on cancer type and stage.
- Significant progress has been made in developing targeted autophagy-modulating therapies.
Conclusions:
- Precise understanding of autophagy mechanisms is essential for effective cancer therapy.
- Tailoring autophagy modulators to specific cancer types is critical for therapeutic success.
- Further research into autophagy modulation holds promise for overcoming cancer treatment resistance.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Stabilize Microtubules
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Inhibition of Cdk Activity
Drugs that Destabilize Microtubules

